FDA Import Refusal 799-1158364-5/10002/1 — LAFAGE LABORATORIES
The FDA refused shipment 799-1158364-5/10002/1 from LAFAGE LABORATORIES (Guatemala) on February 26, 2026. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- February 26, 2026
- Country
- Guatemala
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75